Key result
RAAS hyperactivation drives cardiorenal syndrome pathogenesis via oxidative stress and uremic toxin overload.
Why the study?
Cardiorenal syndrome exhibits high morbidity and mortality, and understanding the mechanism of renin-angiotensin-aldosterone system activation can identify intervention targets to reduce end-stage organ damage.
This review highlights the central role of RAAS activation in the pathogenesis of cardiorenal syndrome through oxidative stress, uremic toxin retention, and ADMA production, suggesting multiple targets for therapeutic intervention.
Supports RAAS blockade as key in cardiorenal syndrome; hypothesis-generating for multi-pathway targets pending prospective trials.
Cardiorenal syndrome (CRS), a clinical syndrome involving multiple pathological mechanisms, exhibits high morbidity and mortality. According to the primary activity of the disease, CRS can be divided into cardiorenal syndrome (type I and type II), renal heart syndrome (type III and type IV), and secondary heart and kidney disease (type V). The renin-angiotensin-aldosterone system (RAAS) is an important humoral regulatory system of the body that exists widely in various tissues and organs. As a compensatory mechanism, the RAAS is typically activated to participate in the regulation of target organ function. RAAS activation plays a key role in the pathogenesis of CRS. The RAAS induces the onset and development of CRS by mediating oxidative stress, uremic toxin overload, and asymmetric dimethylarginine production. Research on the mechanism of RAAS-induced CRS can provide multiple intervention methods that are of great significance for reducing end-stage organ damage and further improving the quality of life of patients with CRS.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2022) conducted a review in Cardiorenal syndrome. Renin-Angiotensin-Aldosterone System (RAAS) activation was evaluated. Excessive activation of the renin-angiotensin-aldosterone system plays a key role in the pathogenesis of cardiorenal syndrome by mediating oxidative stress, uremic toxin overload, and ADMA production.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: